RIPK3 and melanoma: For the first time, it has now become clear that RIPK3 acts as an epigenetically regulated tumor suppressor in melanoma; its re- or overexpression likely causes an induction of necroptosis, which results in an inhibition of tumor cell proliferation in melanoma and HEK.